(CIDRAP News) A new diagnostic tool that involves thousands of fragments of genetic material on a glass slide can identify a vast range of different pathogens, including viruses, bacteria, fungi, and parasites, according to a report from an international team of researchers.
(CIDRAP News) Scientists say they have developed an inexpensive "gene chip" test that can quickly identify a variety of influenza A viruses, including H5N1, and is less apt to be confused by viral mutations than other tests are.
(CIDRAP News) Government researchers reported this week that they have developed a vaccine that protects mice from the deadly 1918 "Spanish flu" virus, demonstrating that immunization against it is possible.
(CIDRAP News) The human immune system may respond better to a vaccine for a new strain of H5N1 avian influenza if it is prepared in advance with a vaccine based on an existing H5N1 strain, the preliminary results of a government-sponsored study suggest.
(CIDRAP News) Public health and infectious disease experts today called on the United States to develop a "master plan" for development of pandemic influenza vaccines in order to translate scientific advances more rapidly into improved pandemic preparedness.
(CIDRAP News) A study in which mice were infected with the resurrected 1918 Spanish influenza virus has yielded fresh evidence for the view that the virus could trigger a suicidal immune responseone that has often been compared with the effects of the H5N1 avian flu virus on susceptible humans.
(CIDRAP News) Scientists reported yesterday that an experimental vaccine triggered a good immune response to H9N2 avian influenza virus, a type that has caused a few human infections and is considered capable of evolving into a pandemic strain.
(CIDRAP News) Live-virus vaccines made from a combination of H5N1 avian influenza virus and another flu strain protected laboratory mice and ferrets from deadly infection with several different H5N1 strains, according to a report published yesterday.
(CIDRAP News) Vical Inc., San Diego, announced today it would receive early access to $2.6 million in government funds to help it complete preclinical development of a DNA vaccine for avian influenza.